发明授权
- 专利标题: Benzimidazole derivatives and preparation process and pharmaceutical uses thereof
-
申请号: US15123961申请日: 2015-03-18
-
公开(公告)号: US09708306B2公开(公告)日: 2017-07-18
- 发明人: Jian Ge , Jianyi Ma , Guangya Xiang , Wei Wang , Chaodong Wang
- 申请人: WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD , WUHAN QR PHARMACEUTICALS CO., LTD
- 申请人地址: CN Wuhan, Hubei CN Wuhan, Hubei
- 专利权人: WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD,WUHAN QR PHARMACEUTICALS CO., LTD
- 当前专利权人: WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD,WUHAN QR PHARMACEUTICALS CO., LTD
- 当前专利权人地址: CN Wuhan, Hubei CN Wuhan, Hubei
- 代理机构: Novick, Kim & Lee, PLLC
- 代理商 Allen Xue
- 国际申请: PCT/CN2015/074426 WO 20150318
- 国际公布: WO2016/145622 WO 20160922
- 主分类号: C07D413/10
- IPC分类号: C07D413/10 ; A61K31/4245 ; A61K31/497 ; A61K31/501 ; C07D403/14 ; C07D493/04 ; C07D498/18 ; C07D413/14
摘要:
The invention belongs to the technical field of pharmaceutical chemistry, and particularly pertains to benzimidazole derivatives, and preparation process and pharmaceutical uses thereof. Benzimidazole derivatives include Ligustrazine and NO donor derivatives. The kind of the compounds can rapidly release Ligustrazine or No in vivo, so that they can produce effective synergetic effects with Azilsartan, to enhance the anti-hypertension effect, and reduce adverse effects, and the released Ligustrazine can produce ideal protection to patients' livers and kidneys, thereby filling blanks in the prior art.
公开/授权文献
信息查询